Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 16;9(9):2986.
doi: 10.3390/jcm9092986.

A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients' Lives and Allografts

Affiliations
Review

A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients' Lives and Allografts

Smaragdi Marinaki et al. J Clin Med. .

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has posed a significant challenge to physicians and healthcare systems worldwide. Evidence about kidney transplant (KTx) recipients is still limited. A systematic literature review was performed. We included 63 articles published from 1 January until 7 July 2020, reporting on 420 adult KTx recipients with confirmed COVID-19. The mean age of patients was 55 ± 15 years. There was a male predominance (67%). The majority (74%) were deceased donor recipients, and 23% were recently transplanted (<1 year). Most patients (88%) had at least one comorbidity, 29% had two, and 18% three. Ninety-three percent of cases were hospitalized. Among them, 30% were admitted to the intensive care unit, 45% developed acute respiratory distress syndrome, and 44% had acute kidney injury with 23% needing renal replacement therapy. From the hospitalized patients a total of 22% died, 59% were discharged, and 19% were still in hospital at the time of publication. Immunosuppression was reduced in 27%, discontinued in 31%, and remained unchanged in 5%. Hydroxychloroquine was administered to 78% of patients, antibiotics to 73%, and antivirals to 30% while 25% received corticosteroid boluses, 28% received anti-interleukin agents, and 8% were given immunoglobulin. The main finding of our analysis was that the incidence of COVID-19 among kidney transplant patients is not particularly high, but when they do get infected, this is related to significant morbidity and mortality.

Keywords: COVID-19 infection; immunosuppression; kidney transplantation; outcomes; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of the systematic literature search according to the Preferred Reported Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. COVID-19: coronavirus disease 2019.

Similar articles

Cited by

References

    1. Sun P., Lu X., Xu C., Sun W., Pan B. Understanding of COVID-19 based on current evidence. J. Med. Virol. 2020;92:548–551. doi: 10.1002/jmv.25722. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention People with Underlying Medical Conditions, Immunocompromised State (Weakened Immune System) from Solid Organ Transplant. [(accessed on 30 July 2020)];2020 Available online: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-....
    1. Akalin E., Azzi Y., Bartash R., Seethamraju H., Parides M., Hemmige V., Ross M., Forest S., Goldstein Y.D., Ajaimy M., et al. Covid-19 and Kidney Transplantation. N. Engl. J. Med. 2020;382:2475–2477. doi: 10.1056/NEJMc2011117. - DOI - PMC - PubMed
    1. Pereira M.R., Mohan S., Cohen D.J., Husain S.A., Dube G.K., Ratner L.E., Arcasoy S., Aversa M.M., Benvenuto L.J., Dadhania D.M., et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am. J. Transpl. 2020;20:1800–1808. doi: 10.1111/ajt.15941. - DOI - PMC - PubMed
    1. Fishman J.A. Infection in solid-organ transplant recipients. N. Engl. J. Med. 2007;357:2601–2614. doi: 10.1056/NEJMra064928. - DOI - PubMed

LinkOut - more resources